The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final analysis: Randomized, blinded, placebo-controlled phase II trial of sorafenib with and without mapatumumab in patients with advanced hepatocellular carcinoma (HCC).
Tudor-Eliade Ciuleanu
No relevant relationships to disclose
Igor Bazin
Research Funding - Federal State Budgetary Institution, Russian Oncology Research Center
Dan Lungulescu
Research Funding - DERMA 111982
Lucian Miron
No relevant relationships to disclose
Igor Bondarenko
No relevant relationships to disclose
Andrzej Deptala
Honoraria - Bayer
Maribel Rodriguez-Torres
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Janssen Research & Development; Merck Sharp & Dohme; Roche; Santaris; SCYNEXIS Inc.; Vertex
Research Funding - AbbVie; Beckman Coulter; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Gilead Sciences; GlaxoSmithKline; Human Genome Sciences; Idenix; Idera; Johnson & Johnson; Merck Sharp & Dohme; Mochida Pharmaceutical Co. Ltd.; Novartis; Pfizer; Roche; Santaris; SCYNEXIS Inc.; Siemens Healthcare Diagnostics; Vertex; Zymogenetics
Bruce J. Giantonio
No relevant relationships to disclose
Weijing Sun
No relevant relationships to disclose
Norma Lynn Fox
Employment or Leadership Position - GlaxoSmithKline; Human Genome Sciences
Stock Ownership - GlaxoSmithKline; Human Genome Sciences
Gursel Aktan
Employment or Leadership Position - GlaxoSmithKline (B)
Stock Ownership - GlaxoSmithKline (B)
Paul Stephen Wissel
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Jacki Egger
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Meichun Ding
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Rubana Kalyani
Employment or Leadership Position - GlaxoSmithKline
Matthew Joseph Gribbin
Employment or Leadership Position - Human Genome Sciences